151 related articles for article (PubMed ID: 38054081)
1. Roles of Fatty Acid Chain Length and Enzyme-Oriented Drug Controlled Release from pH-Triggering Self-Assembled Fatty Acid Conjugated Quetiapine Nanosuspensions.
Nguyen HD; Ngo HV; Nguyen VH; Gil MC; Lee BJ
Int J Nanomedicine; 2023; 18():7115-7131. PubMed ID: 38054081
[TBL] [Abstract][Full Text] [Related]
2. The roles of short and long chain fatty acids on physicochemical properties and improved cancer targeting of albumin-based fattigation-platform nanoparticles containing doxorubicin.
Park C; Meghani N; Amin H; Tran PH; Tran TT; Nguyen VH; Lee BJ
Int J Pharm; 2019 Jun; 564():124-135. PubMed ID: 30991133
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyl Group-Targeted Conjugate and Its Self-Assembled Nanoparticle of Peptide Drug: Effect of Degree of Saturation of Fatty Acids and Modification of Physicochemical Properties.
Park J; Ngo HV; Jin HE; Lee KW; Lee BJ
Int J Nanomedicine; 2022; 17():2243-2260. PubMed ID: 35615542
[TBL] [Abstract][Full Text] [Related]
4. Effect of phosphatidylcholine in bentonite-quetiapine complex on enhancing drug release and oral bioavailability.
Baek MJ; Kim GH; Park JH; Kim J; Kang IM; Lee JI; Kim DD
Int J Pharm; 2022 Nov; 628():122347. PubMed ID: 36349613
[TBL] [Abstract][Full Text] [Related]
5. Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
Park C; Baek N; Loebenberg R; Lee BJ
J Control Release; 2020 Aug; 324():55-68. PubMed ID: 32380202
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid chain length impacts nanonizing capacity of albumin-fatty acid nanomicelles: Enhanced physicochemical property and cellular delivery of poorly water-soluble drug.
Park C; Meghani N; Loebenberg R; Cui JH; Cao QR; Lee BJ
Eur J Pharm Biopharm; 2020 Jul; 152():257-269. PubMed ID: 32422167
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia.
Akhlaq M; Maryam F; Elaissari A; Ullah H; Adeel M; Hussain A; Ramzan M; Ullah O; Zeeshan Danish M; Iftikhar S; Aziz N
Drug Deliv; 2018 Nov; 25(1):916-927. PubMed ID: 29649903
[TBL] [Abstract][Full Text] [Related]
8. Comparative Physicochemical and Pharmacokinetic Properties of Quetiapine and Its Active Metabolite Norquetiapine.
Kim DW; Weon KY; Hong EP; Chung EK; Lee KT
Chem Pharm Bull (Tokyo); 2016; 64(11):1546-1554. PubMed ID: 27803466
[TBL] [Abstract][Full Text] [Related]
9. Utilization of a fattigation platform gelatin-oleic acid sodium salt conjugate as a novel solubilizing adjuvant for poorly water-soluble drugs via self-assembly and nanonization.
Kim D; Park C; Meghani NM; Tran TTD; Tran PHL; Park JB; Lee BJ
Int J Pharm; 2020 Feb; 575():118892. PubMed ID: 31786354
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose-response model-based network meta-analysis.
Terao I; Yokoi A; Fukushima H
J Psychopharmacol; 2023 Oct; 37(10):953-959. PubMed ID: 37740667
[TBL] [Abstract][Full Text] [Related]
12. Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine.
Okada M; Fukuyama K; Motomura E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012369
[TBL] [Abstract][Full Text] [Related]
13. Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43.
Fukuyama K; Okada M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070699
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs.
Van Ngo H; Park C; Tran TTD; Nguyen VH; Lee BJ
Eur J Pharm Biopharm; 2020 Sep; 154():8-17. PubMed ID: 32634569
[TBL] [Abstract][Full Text] [Related]
16. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
Hamed R; AlJanabi R; Sunoqrot S; Abbas A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
[TBL] [Abstract][Full Text] [Related]
17. Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant.
Yu Y; Ngo HV; Jin G; Tran PHL; Tran TTD; Nguyen VH; Park C; Lee BJ
Int J Nanomedicine; 2021; 16():2819-2831. PubMed ID: 33888982
[TBL] [Abstract][Full Text] [Related]
18. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms.
Vervaeck A; Saerens L; De Geest BG; De Beer T; Carleer R; Adriaensens P; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):587-96. PubMed ID: 23474381
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylcholine-fatty acid membranes. I. Effects of protonation, salt concentration, temperature and chain-length on the colloidal and phase properties of mixed vesicles, bilayers and nonlamellar structures.
Cevc G; Seddon JM; Hartung R; Eggert W
Biochim Biophys Acta; 1988 May; 940(2):219-40. PubMed ID: 2835979
[TBL] [Abstract][Full Text] [Related]
20. Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose.
Li KY; Li X; Cheng ZN; Li HD
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):83-6. PubMed ID: 15834460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
